Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. This Phase 2 study, officially titled “A Phase 2, Multicen......

Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. This Phase 2 study, officially titled “A Phase 2, Multicen......

Vanguard S&P 500 ETF ($VOO) remains one of the most popular choices for investors seeking broad exposure to the U.S. stock market. However, as mark......

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Editas Medicine (EDIT), Vertex Pharmaceuticals (VRTX......

RBC Capital analyst Brian Abrahams maintained a Buy rating on Vertex Pharmaceuticals yesterday and set a price target of $543.00. The company’s sha......

In a report released today, Paul Matteis from Stifel Nicolaus maintained a Hold rating on Vertex Pharmaceuticals, with a price target of $466.00. M......

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Addus Homecare (ADUS), Vertex Pharmaceuticals (VRTX)......

In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on Vertex Pharmaceuticals, with a price target of $616.00. Fl......

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX) and Evolus (EOLS) with......

Here’s a look at today’s key earnings reports from major publicly traded companies. Stock market investors will undoubtedly be watching closely for......